3-Bromopyruvate is known for glycolytic inhibitors. Potential target is hexoknase II and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
|Catalog #||Material Name||Company Name||Solute/Solvent|
In vitro test:
Dissolve in distilled water to make a 0.5 M stock solution. Aliquote and store at -20 degree
1. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009; 325:1555. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Wilson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N.
|From pipettes to automation to calibration, the total solution for all of your liquid handling needs.|
|Antibodies from Epitomics|
|Over 6800 high quality antibodies from Epitomics. All Epitomics antibodies are validated in WB, IHC, ICC/IF, IP and FACS. Learn more|
|Custom Target Enrichment|
|GenCapTM technology captures both strands from custom genomic target regions with superior evenness for reduced sequencing costs.|